We are live on ! Find out more
HSTO

Histogen Inc. Common Stock

Delisted

HSTO was delisted on the 4th of October, 2023.

37 hedge funds and large institutions have $30.9M invested in Histogen Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

50% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 8

12% more funds holding

Funds holding: 3337 (+4)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

10% less capital invested

Capital invested by funds: $34.3M → $30.9M (-$3.4M)

17% less call options, than puts

Call options by funds: $380K | Put options by funds: $460K

Holders
37
Holders Change
+4
Holders Change %
+12.12%
% of All Funds
1.03%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
7
Increased
12
Reduced
8
Closed
3
Calls
$380K
Puts
$460K
Net Calls
-$80K
Net Calls Change
-$209K

HSTO Hedge Fund Activity: Q3 2015 in Review

37 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q3 2015, worth a combined $30.9M — down 9.9% from $34.3M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new HSTO positions and 3 closed out — a net gain of 4 holders — while 12 added to existing stakes and 8 trimmed.

The largest buyer was Millennium Management, adding an estimated $1.85M. The largest seller was Sabby Management, cutting an estimated $1.42M.

  • 37 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q3 2015, up from 33 in Q2 2015.
  • Funds reported $30.9M of Histogen Inc. Common Stock stock for Q3 2015, down 9.9% quarter-over-quarter.
  • 7 funds opened new Histogen Inc. Common Stock positions in Q3 2015 and 3 closed out, a net change of +4 holders.
  • The largest Histogen Inc. Common Stock buyer in Q3 2015 was Millennium Management, an estimated $1.85M added.
  • The largest Histogen Inc. Common Stock seller in Q3 2015 was Sabby Management, an estimated $1.42M sold.

Based on aggregated 13F filings for Q3 2015.